DDB wins Johnson & Johnson Medical in South Korea

The pitch, which took place in late February, also included McCann, Ogilvy & Mather and the incumbent, a small local agency called Crenor, according to DDB. However, a spokesperson for McCann said that neither McCann and McCann Health was involved in the pitch.

DDB Group will focus on campaigns for Johnson & Johnson’s LifeScan brands in Korea, with work expected to roll out beginning this month. The first campaign will be for the OneTouch blood glucose monitoring meter. OneTouch currently holds second position, behind Accu-chek from Loche, among more than 70 competing diabetic monitoring brands in Korea, according to DDB. 

The client cited DDB's "strategic and creative approach, as well as their high level of understanding of our brand’s mission" for the selection.

The prevalence of diabetes among Korean adults aged 20 to 79 years in 2010 was estimated at 9.0 per cent and is expected to rise to 11.4 per cent in 2030, according to the International Diabetes Federation.

Updated, 4:30 pm, 13 May 2013: Second paragraph edited to clarify that neither McCann nor McCann Health took part in the pitch, according to a McCann spokesperson.